Literature DB >> 33748827

Early Insights into COVID-19 in Persons Living with HIV and Cardiovascular Manifestations.

Jelani K Grant1, Louis Vincent1, Bertrand Ebner1, Barry E Hurwitz2,3,4, Maria L Alcaide5, Claudia Martinez6.   

Abstract

Persons living with HIV-1 (PLHIV) are at increased risk of cardiovascular complications in part due to the persistent inflammatory state despite viral suppression. SARS-CoV-2, the virus causing COVID-19, was declared a pandemic virus in March 2020, and caused over 30 million cases and 900,000 deaths worldwide to date. Individuals with COVID-19 are manifesting acute cardiovascular complications because of the inflammatory response associated with SARS-CoV-2 infection. It is not yet known whether having COVID-19 in the context of ongoing HIV-1 infection results in worse cardiovascular complications than in PLHIV who have not had COVID-19 infection. In this review, the potential for exacerbated cardiovascular manifestations in persons coinfected with HIV-1 and COVID-19 is considered.

Entities:  

Year:  2020        PMID: 33748827      PMCID: PMC7971556          DOI: 10.33696/aids.2.010

Source DB:  PubMed          Journal:  J AIDS HIV Treat


  61 in total

1.  The Broad Spectrum of HIV-Related Cardiovascular Disease.

Authors:  Monica R Shah
Journal:  JACC Heart Fail       Date:  2015-07-08       Impact factor: 12.035

2.  Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response.

Authors:  Giacomo Grasselli; Antonio Pesenti; Maurizio Cecconi
Journal:  JAMA       Date:  2020-04-28       Impact factor: 56.272

3.  Comorbidities in Persons With HIV: The Lingering Challenge.

Authors:  Andrea M Lerner; Robert W Eisinger; Anthony S Fauci
Journal:  JAMA       Date:  2020-01-07       Impact factor: 56.272

4.  Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study.

Authors:  Jonathan A C Sterne; Miguel A Hernán; Bruno Ledergerber; Kate Tilling; Rainer Weber; Pedram Sendi; Martin Rickenbach; James M Robins; Matthias Egger
Journal:  Lancet       Date:  2005 Jul 30-Aug 5       Impact factor: 79.321

5.  Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19).

Authors:  Riccardo M Inciardi; Laura Lupi; Gregorio Zaccone; Leonardo Italia; Michela Raffo; Daniela Tomasoni; Dario S Cani; Manuel Cerini; Davide Farina; Emanuele Gavazzi; Roberto Maroldi; Marianna Adamo; Enrico Ammirati; Gianfranco Sinagra; Carlo M Lombardi; Marco Metra
Journal:  JAMA Cardiol       Date:  2020-07-01       Impact factor: 14.676

6.  Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease.

Authors:  Chris Tikellis; M C Thomas
Journal:  Int J Pept       Date:  2012-03-20

Review 7.  The role of HIV Tat protein in HIV-related cardiovascular diseases.

Authors:  Yanan Jiang; Lu Chai; Moyondafoluwa Blessing Fasae; Yunlong Bai
Journal:  J Transl Med       Date:  2018-05-08       Impact factor: 5.531

8.  Endothelial cell infection and endotheliitis in COVID-19.

Authors:  Zsuzsanna Varga; Andreas J Flammer; Peter Steiger; Martina Haberecker; Rea Andermatt; Annelies S Zinkernagel; Mandeep R Mehra; Reto A Schuepbach; Frank Ruschitzka; Holger Moch
Journal:  Lancet       Date:  2020-04-21       Impact factor: 79.321

Review 9.  Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis.

Authors:  Giuseppe Lippi; Carl J Lavie; Fabian Sanchis-Gomar
Journal:  Prog Cardiovasc Dis       Date:  2020-03-10       Impact factor: 8.194

10.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

View more
  1 in total

Review 1.  Tenofovir, Another Inexpensive, Well-Known and Widely Available Old Drug Repurposed for SARS-COV-2 Infection.

Authors:  Isabella Zanella; Daniela Zizioli; Francesco Castelli; Eugenia Quiros-Roldan
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.